Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Aran Research & Development (1982)'s Return-on-Tangible-Equity or its related term are showing as below:
XTAE:ARAN'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 4.82 Med: 16.53 Max: 31.84
Current: 20.82
During the past 13 years, Aran Research & Development (1982)'s highest Return-on-Tangible-Equity was 31.84%. The lowest was 4.82%. And the median was 16.53%.
XTAE:ARAN's Return-on-Tangible-Equity is ranked better than 81.82% of 539
companies
in the Conglomerates industry
Industry Median: 7.88
vs XTAE:ARAN: 20.82
Aran Research & Development (1982) (XTAE:ARAN) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Aran Research & Development (1982) Return-on-Tangible-Equity Related Terms
Aran Research & Development (1982) Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aran Research & Development (1982) Return-on-Tangible-Equity Chart
XTAE:ARAN vs MMM, HON: Return-on-Tangible-Equity Comparison
For the Conglomerates subindustry, Aran Research & Development (1982)'s Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aran Research & Development (1982) Return-on-Tangible-Equity vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Aran Research & Development (1982)'s Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Aran Research & Development (1982)'s Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 28.85% mean?
Aran Research & Development (1982) (XTAE:ARAN) has a Return-on-Tangible-Equity of 28.85% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aran Research & Development (1982) and its competitors. This is 75% above median its historical median of 16.53. Over the past decade, Aran Research & Development (1982)'s Return-on-Tangible-Equity has ranged from 4.82 to 31.84. According to the industry distribution chart, Aran Research & Development (1982) ranks #98 out of 539 companies in the Conglomerates industry, placing it in the top 18.2%.
Is Aran Research & Development (1982)'s Return-on-Tangible-Equity too high?
Aran Research & Development (1982)'s current Return-on-Tangible-Equity of 28.85% is 75% above median its 10-year median of 16.53. Over the past 10 years, this metric has ranged from a low of 4.82 to a high of 31.84. The Conglomerates industry median Return-on-Tangible-Equity is 7.88. Aran Research & Development (1982)'s value of 28.85% is 266.1% above this industry median. Based on the distribution chart, Aran Research & Development (1982) ranks #98 out of 539 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, Aran Research & Development (1982) has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aran Research & Development (1982)'s Return-on-Tangible-Equity compare to MMM and HON?
According to the Conglomerates industry distribution chart, Aran Research & Development (1982) ranks #98 out of 539 companies for Return-on-Tangible-Equity. This places Aran Research & Development (1982) in the top 18% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 7.88. Aran Research & Development (1982)'s value of 28.85% is 266.1% above this benchmark. Historically, Aran Research & Development (1982)'s own Return-on-Tangible-Equity has ranged from 4.82 to 31.84 over the past decade. While the company's 10-year median is 16.53 vs. the industry median of 7.88, Aran Research & Development (1982) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Conglomerates company?
The median Return-on-Tangible-Equity among Conglomerates companies is 7.88, based on 539 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aran Research & Development (1982)'s current Return-on-Tangible-Equity of 28.85% is 266.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aran Research & Development (1982) and its competitors. For the Conglomerates industry, the median Return-on-Tangible-Equity is 7.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aran Research & Development (1982)'s current Return-on-Tangible-Equity is 28.85%, which is 75% above median its own 10-year median of 16.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aran Research & Development (1982) stock overvalued right now?
Based on GuruFocus' analysis, Aran Research & Development (1982) (XTAE:ARAN) is currently considered Fairly Valued. The stock's GF Value™ is ₪37.11, compared to a current price of ₪39.78 — trading 7.2% above its estimated fair value. The current Return-on-Tangible-Equity is 28.85%, which is 75% above median its 10-year median of 16.53 and 266.1% above the Conglomerates industry median of 7.88. Aran Research & Development (1982)'s overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Aran Research & Development (1982) (XTAE:ARAN), the current Return-on-Tangible-Equity is 28.85% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aran Research & Development (1982) (XTAE:ARAN) Overvalued in 2026?
Based on GuruFocus' analysis, Aran Research & Development (1982) stock appears to be overvalued.
The current stock price of ₪39.78 is trading 7.2% above its estimated GF Value™ of ₪37.11.
GuruFocus considers Aran Research & Development (1982) to be Fairly Valued.
Key valuation signals for XTAE:ARAN:
Return-on-Tangible-Equity: 28.85% (75% above median its 10-year median of 16.53)
GF Value™: ₪37.11 vs. price of ₪39.78 (7.2% above fair value)
Industry Position: 266.1% above the Conglomerates median (#98 of 539)
No single metric tells the full story. See the XTAE:ARAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aran Research & Development (1982) Ltd is a product design and development company. It also manufactures equipment for the plastics industry. It develops & supplies products including medical devices, water, defense & HLS, consumer & industrial and injection molds. It also has medical startups which focuses on Cardiovascular, Laparoscopy and Gastrointestinal endoscopy.
78GF Score
Get the complete analysis for XTAE:ARAN
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ARAN has been successfully added to your 
